Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are 
associated with risk for and mortality from cancer in a German primary care 
cohort

Baur, D. M.; Klotsche, J.; Hamnvik, O. P. R.; Sievers, C.; Pieper, L.; Wittchen, H. U.; Stalla, G. K.; Schmid, R. M.; Kales, S. N.; Mantzoros, C. S.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

MPS-Authors

/persons/resource/persons80528

Sievers, C.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80592

Wittchen, H. U.
Max Planck Institute of Psychiatry, Max Planck Society;

Stalla, G. K.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Baur, D. M., Klotsche, J., Hamnvik, O. P. R., Sievers, C., Pieper, L., Wittchen, H. U., et al. (2011). Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism-Clinical and Experimental, 60(10), 1363-1371.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-8D96-A

Abstract

There is no abstract available